What are the normal Fasting Blood Sugar (FBS) and Postprandial Blood Sugar (PPBS) readings in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Blood Glucose Targets in Pregnancy

For pregnant women with gestational diabetes or pre-existing diabetes, the recommended targets are: fasting glucose <95 mg/dL (5.3 mmol/L), 1-hour postprandial <140 mg/dL (7.8 mmol/L), and 2-hour postprandial <120 mg/dL (6.7 mmol/L). 1, 2

Target Glucose Values

The most recent American Diabetes Association guidelines (2023) establish clear glycemic targets for all pregnant women with diabetes, whether gestational or pre-existing 1:

Fasting Blood Sugar (FBS)

  • Target: 70-95 mg/dL (3.9-5.3 mmol/L) 1
  • The upper limit of 95 mg/dL is the critical threshold for treatment decisions 1, 2
  • The lower limit of 70 mg/dL protects against hypoglycemia while the upper limit prevents fetal complications 1

Postprandial Blood Sugar (PPBS)

You have two monitoring options 1:

Option 1: One-hour postprandial

  • Target: 110-140 mg/dL (6.1-7.8 mmol/L) 1
  • Upper limit of 140 mg/dL is the treatment threshold 1, 2

Option 2: Two-hour postprandial

  • Target: 100-120 mg/dL (5.6-6.7 mmol/L) 1
  • Upper limit of 120 mg/dL is the treatment threshold 1, 2

Monitoring Strategy

For Women with Gestational Diabetes

  • Perform fasting and postprandial blood glucose monitoring daily 1
  • Postprandial monitoring is superior to preprandial monitoring for achieving optimal outcomes and reducing preeclampsia risk 1
  • Check fasting glucose every morning and either 1-hour or 2-hour after each meal 1, 3

For Women with Pre-existing Diabetes (Type 1 or Type 2)

  • More intensive monitoring is required with at least 4 measurements daily 1
  • Include preprandial testing when using insulin pumps or basal-bolus therapy to adjust rapid-acting insulin doses 1

Critical Thresholds for Treatment Decisions

When to Initiate Insulin Therapy

If medical nutrition therapy fails to maintain glucose below these levels, insulin therapy must be started 1, 3:

  • Fasting glucose ≥95 mg/dL 1, 2
  • 1-hour postprandial ≥140 mg/dL 1, 2
  • 2-hour postprandial ≥120 mg/dL 1, 2

Early Pregnancy Screening Thresholds

At the first prenatal visit, different thresholds apply for diagnosis 2:

  • Fasting glucose <92 mg/dL: Normal, retest at 24-28 weeks 2
  • Fasting glucose 92-125 mg/dL: Early gestational diabetes, start treatment immediately 2
  • Fasting glucose ≥126 mg/dL: Overt pre-existing diabetes, not gestational diabetes 2, 4, 5

HbA1c Targets

Target HbA1c <6% (42 mmol/mol) if achievable without significant hypoglycemia 1, 2

  • HbA1c may be relaxed to <7% (53 mmol/mol) if needed to prevent hypoglycemia 1
  • HbA1c should be measured monthly during pregnancy due to increased red blood cell turnover 1
  • Important caveat: HbA1c is a secondary measure; self-monitoring of blood glucose is the primary tool for day-to-day management 1

Common Pitfalls to Avoid

Timing of Postprandial Measurements

  • Measure 1-hour postprandial after breakfast (highest abnormal rate occurs at this time) 6
  • Measure 2-hour postprandial after dinner (highest abnormal rate occurs at this time) 6
  • The rate of abnormal values is 2.5-fold greater at 1-hour post-breakfast versus 2-hour post-breakfast 6

Fasting Glucose Monitoring

  • Never omit fasting glucose measurements 7
  • While normal fasting glucose (<105 mg/dL) predicts normal 2-hour postprandial values 96% of the time, fasting glucose is the most critical value for treatment decisions 7
  • Fasting glucose >105 mg/dL requires immediate insulin therapy regardless of postprandial values 1

Hypoglycemia Risk

  • Women with type 1 diabetes may struggle to achieve these targets without hypoglycemia, particularly those with hypoglycemia unawareness 1
  • In early pregnancy (first trimester), insulin requirements decrease and hypoglycemia risk increases 1
  • If targets cannot be achieved safely, slightly higher individualized targets may be necessary 1

Physiologic Context

Normal Pregnancy Changes

  • Fasting glucose decreases by approximately 3 mg/dL in the first trimester (from 81 to 78 mg/dL) 8
  • Further slight decrease occurs in the third trimester (median 76 mg/dL) 8
  • After delivery, fasting glucose increases sharply (84 mg/dL in puerperium) 8

Insulin Resistance Progression

  • Insulin sensitivity is enhanced in early pregnancy with lower insulin requirements 1
  • Around 16 weeks, insulin resistance begins increasing exponentially 1
  • Total daily insulin dose typically doubles by the third trimester compared to pre-pregnancy requirements 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria and Management of Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initiating Regular Insulin with Breakfast for Gestational Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Gestational diabetes mellitus (Update 2019)].

Wiener klinische Wochenschrift, 2019

Research

[Gestational diabetes mellitus (Update 2023)].

Wiener klinische Wochenschrift, 2023

Research

One or two hours postprandial glucose measurements: are they the same?

American journal of obstetrics and gynecology, 2001

Related Questions

What care is recommended for a pregnant woman with a Body Mass Index (BMI) of 24, no history of Gestational Diabetes Mellitus (GDM), and a normal pregnancy?
How is gestational diabetes (GDM) resolved postpartum?
How to manage a 28-week primigravida (first-time pregnant woman) at 37 weeks gestation with a random blood sugar level of 213 mg/dl at 7 am, indicating hyperglycemia?
Is a 1-hour Oral Glucose Tolerance Test (OGTT) result of 212 mg/dL at 11 weeks gestation indicative of gestational diabetes mellitus (GDM) or type 2 diabetes?
What are the target postprandial (after meal) glucose levels in pregnant women with gestational diabetes?
What to do for a patient with diabetes on Mixtard (insulin) and hydrocortisone (cortisol) who developed hypoglycemia after increasing morning insulin dose from 35 to 37 units?
Where should a patient with Diabetic Ketoacidosis (DKA) and End-Stage Renal Disease (ESRD) on hemodialysis be referred for further management?
What is the role of the Q (cotton swab) tip test in diagnosing vaginal vault prolapse or urethral axis abnormality in a patient with suspected pelvic floor dysfunction?
What is the risk stratification approach for a patient with Gastrointestinal Stromal Tumor (GIST)?
What is the appropriate diagnosis and treatment approach for an adult patient with non-caseating granulomas and a positive Gene Xpert MTB (Mycobacterium Tuberculosis) trace?
What are the indications for blood transfusion in patients with iron deficiency anemia, particularly in those with severe symptoms or comorbidities such as cardiovascular disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.